Navigation Links
Results and Additional Analyses From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Date:5/28/2009

SAN MATEO¿ Calif.¿ May 28 /PRNewswire/ -- Results and additional analyses from the Phase II portion of a Phase II/III clinical trial of Corthera's investigational drug relaxin for the treatment of acute heart failure will be presented at the Heart Failure Congress, the annual meeting of the Heart Failure Association of the European Society of Cardiology in Nice, France.

Marco Metra, M.D., professor of cardiology at the University of Brescia, Italy, and co-principal investigator of the Pre-RELAX-AHF study, will present the main results from the multicenter, international Pre-RELAX-AHF study at 8:30 a.m. CET on Sunday, May 31, at the Judges' Choice oral abstracts session. Dr. Metra will also present additional analyses of the Pre-RELAX-AHF study during a late-breaking clinical trials session at 11:15 a.m. CET on Monday, June 1. Five posters from the Pre-RELAX-AHF study will also be presented from 8:30 a.m. to 12:30 p.m. CET on Monday, June 1.

About Relaxin

Relaxin is a naturally occurring peptide hormone that acts as a systemic and renal vasodilator. Elevated levels of relaxin modulate increases in renal and cardiac function that meet the increased hemodynamic demands of pregnancy. Consistent with this natural role of the hormone, pharmaceutically manufactured relaxin has been shown to have these effects in multiple human studies of men and non-pregnant women, including patients with heart failure.

About Corthera

Corthera Inc. is a private biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera's lead product candidate, relaxin, is currently being evaluated in clinical trials for acute heart failure. The company has worldwide rights to develop and commercialize relaxin. For more information, visit www.corthera.com. <
'/>"/>

SOURCE Corthera Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,Fla., Nov.25/PRNewswire-FirstCall/--AmericanScie...ispleasedtoannouncethattheyhaveopenedaregionalmark.... ,, ASRhasbeenabletosecurealocationabroad,prov...ionofcurrentandfuturehealthandsafetyproductsforchi...ntlythecompanyhousesinventoryinthestateofOhiowhere...
(Date:11/25/2009)...TON,N.J.,Nov.25/PRNewswire-FirstCall/--Pharmasset,...mpanycommittedtodiscovering,developingandcommercia...ancialresultsforthefiscalyearendedSeptember30,2009...h,cashequivalentsandshortterminvestments. ,, P..., Phase2bTrial ,, InlateNovember2009,anind...
(Date:11/25/2009)...Pa.,Nov.25/PRNewswire/--BioTrendsResearchGroup,Inc... report,thefirstinamulti-phasesyndicatedmarketrese...h,sStelara,fromproductlaunchthroughthefirstsixmont...tativeinformationfrom75uniqueDermatologistsandqual...trialanduseofStelara,obstaclestouse,typicalpatient...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Dietary Oils May Help Some Fight Fat 51925 1Dietary Oils May Help Some Fight Fat 51925 2Dietary Oils May Help Some Fight Fat 51925 3STD Test Express Offers Free Doctor Consultations With Every STD Test 51921 1STD Test Express Offers Free Doctor Consultations With Every STD Test 51921 2Digitizing Health Records Not Enough 3B Integrated Interoperable Enterprises Vital to U S Healthcare Transformation 51918 1Digitizing Health Records Not Enough 3B Integrated Interoperable Enterprises Vital to U S Healthcare Transformation 51918 2Digitizing Health Records Not Enough 3B Integrated Interoperable Enterprises Vital to U S Healthcare Transformation 51918 3
(Date:11/26/2009)... heavy can lead to strains or worse , , ... nothing wrong with stuffing your turkey full to b...ng with your suitcase as you pack for holiday trip...08 in U.S. hospital emergency rooms, doctors, offi...age-related injuries, such as muscle strains, pull...
(Date:11/26/2009)... David Kim of the Live Life Again Center, a practi...e of a growing number of physicians who are takin...connect with individuals who are interested in sur...y. Dr. Kim is utilizing Facebook to share before-a... with the community. , Da...
(Date:11/26/2009)...is & Ennis, P.A. is offering free nationwide c...min birth control pills who have suffered a Deep V...Heart Attack or other related cardiac issues or ha...ree at 1-800-856-6405 or go to the firm’s we... online case evaluation form. , ...
(Date:11/25/2009)....25/PRNewswire-FirstCall/-- OnyxPharmaceuticals,I...hosttwoinvestoreventsinDecember: ,, ASHBriefi... ,, Principalinvestigatorswilldiscussdatapres...ractorymultiplemyeloma,asfeaturedatthe51stAmerican...inNewOrleans,LA.Theteleconferencewillbeginat9:00a....
(Date:11/25/2009)...25/PRNewswire/--Thanksgivingmealswillbedeliveredto...BeachareathankstoFaithInAction/VolunteerActionforA...visionofSCANHealthPlan.Formorethan17yearstheseorga...warmThanksgivingmealstoseniorsinneedinLongBeach,La...undingcities. ,, "Ourwarmholidaymealsaredeliver...
Breaking Medicine News(10 mins):Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2
...008 Vaccinating infants and toddlers is an almost... to prevent flu are a regular part of medical care...cording to a study published in the August 2008 is... , In response to a request from the Assistant Se...
... have better offerings than high schools, study sa...The kinds of foods that students can purchase at t... less healthy than the food available to children ... 395 schools spread across 129 school districts in...
...) system builds on a 15-year track record of ...rch, KING OF PRUSSIA, PA, July 7 /PRNewswire-Firs...f innovative drug discovery and development,soluti...ersonnel credential management. Aimed at improving...
...m veterans who experienced posttraumatic stress di...rt disease as veterans without PTSD, a new Geising...y issue of Psychosomatic Medicine, Geisinger Sen...The more severe the PTSD diagnosis, the greater th...
...tract Sales Organization And Seek New Marketing ..., LAVAL, QC, July 7 /PRNewswire-FirstCall/ - Labo...d that it has reacquired the sales and,marketing r...e UK, the Company will engage a contract sales org...
...lthough younger people are becoming more positive ...o surrogacy are still broadly negative, a scientis...pean Society of Human Reproduction and Embryology ...vious stigmatisation of surrogate mothers in the m...
Other Medicine News:Health News:National Vaccine Advisory Committee recommends increased adolescent immunization 2Health News:National Vaccine Advisory Committee recommends increased adolescent immunization 3Health News:Secondary Schools Serve Unhealthy Foods 2Health News:Secondary Schools Serve Unhealthy Foods 3Health News:MDS Pharma Services Launches Next Generation Phase I Study Management System 2Health News:Labopharm Reaquires UK Sales And Marketing Rights to Its Once-Daily Tramadol Product 2Health News:Surrogacy still stigmatized, though attitudes changing among younger women 2
Brooks Brothers Ophthalmic Collection
...mour and style. Creativity and cutting-edge design...g companies, signed a new licensing agreement in O...n 1985 by the famous designer duo, Domenico Dolce ...heir Mediterranean roots to create the distinguish...
Michael Kors Eyewear
... accessories world with six handbags that emphasiz...taken her simple aesthetic and evolved the idea in... a nod to the classics, sophisticated use of color...rinciples of the Kate Spade design philosophy. Kat...
Medicine Products: